Get a Quote

CISATRACURIUM BESYLATE
CAS NO.: 96946-42-8
Chemical Formula: C53H72N2O12.2(C6H5O3S)
Molecular Weight: 1243.4800
DMF&GMP status: Please contact us for more details.
Description:
Cisatracurium is used to relax the muscles. It works by blocking the signals between your nerves and your muscles. Cisatracurium is given before general anesthesia in preparing you for surgery. Cisatracurium helps keep your body still during surgery. It also relaxes your throat so a breathing tube can be more easily inserted before the surgery.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
CISATRACURIUM BESYLATEINJECTABLE; INJECTIONEQ 2MG BASE/MLCISATRACURIUM BESYLATEFRESENIUS KABI USA
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 2MG BASE/ML CISATRACURIUM BESYLATE SANDOZ INC
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 10MG BASE/ML CISATRACURIUM BESYLATE PRESERVATIVE FREE FRESENIUS KABI USA
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 2MG BASE/ML CISATRACURIUM BESYLATE PRESERVATIVE FREE FRESENIUS KABI USA
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 10MG BASE/ML CISATRACURIUM BESYLATE PRESERVATIVE FREE SANDOZ INC
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 2MG BASE/ML CISATRACURIUM BESYLATE PRESERVATIVE FREE SANDOZ INC
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 2MG BASE/ML NIMBEX ABBVIE
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 10MG BASE/ML NIMBEX PRESERVATIVE FREE ABBVIE
CISATRACURIUM BESYLATE INJECTABLE; INJECTION EQ 2MG BASE/ML NIMBE ABBVIE
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration